Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Cost of Revenue (2023 - 2025)

Historic Cost of Revenue for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $4.1 million.

  • Bioharvest Sciences' Cost of Revenue rose 2063.21% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 2558.62%. This contributed to the annual value of $11.7 million for FY2024, which is 5143.26% up from last year.
  • Latest data reveals that Bioharvest Sciences reported Cost of Revenue of $4.1 million as of Q3 2025, which was up 2063.21% from $4.0 million recorded in Q2 2025.
  • Bioharvest Sciences' 5-year Cost of Revenue high stood at $4.1 million for Q3 2025, and its period low was $1.6 million during Q2 2023.
  • Its 3-year average for Cost of Revenue is $3.0 million, with a median of $2.9 million in 2023.
  • Over the last 5 years, Bioharvest Sciences' Cost of Revenue had its largest YoY gain of 9015.03% in 2024, and its largest YoY loss of 13.62% in 2024.
  • Over the past 3 years, Bioharvest Sciences' Cost of Revenue (Quarter) stood at $2.9 million in 2023, then grew by 0.14% to $2.9 million in 2024, then soared by 40.2% to $4.1 million in 2025.
  • Its Cost of Revenue stands at $4.1 million for Q3 2025, versus $4.0 million for Q2 2025 and $3.7 million for Q1 2025.